Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Pituitary gland

Mortality in acromegaly reduced with multimodal therapy

Nature Reviews Endocrinology volume 10, pages 708–710 (2014)Cite this article

Subjects

The treatment of patients with acromegaly has progressed to encompass multimodal strategies that can include selective transsphenoidal adenomectomy, radiotherapy and somatostatin analogues. As a result, disease control and survival of these patients has improved.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Mercado, M. et al. Successful mortality reduction and control of co-morbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic. J. Clin. Endocrinol. Metab. http://press.endocrine.org/doi/abs/10.1210/jc.2014-2670.

  2. Dekkers, O. M., Biermasz, N. R., Pereira, A. M., Romijn, J. A. & Vandenbroucke, J. P. Mortality in acromegaly: a metaanalysis. J. Clin. Endocrinol. Metab. 93, 61–67 (2008).

    Article  CAS  Google Scholar 

  3. Holdaway I. M., Bolland M. J. & Gamble G. D. A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur. J. Endocrinol. 159, 89–95 (2008).

    Article  CAS  Google Scholar 

  4. Sherlock, M. et al. Mortality in patients with pituitary disease. Endocr. Rev. 31, 301–342 (2010).

    Article  Google Scholar 

  5. Melmed S. et al. Guidelines for acromegaly management: an update. J. Clin. Endocrinol. Metab. 94, 1509–1517 (2009).

    Article  CAS  Google Scholar 

  6. Bogazzi F. et al. Comparison of the effects of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study. Eur. J. Endocrinol. 169, 367–376 (2013).

    Article  CAS  Google Scholar 

  7. Biermasz N. R. et al. Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements. J. Clin. Endocrinol. Metab. 89, 2789–2796 (2004).

    Article  CAS  Google Scholar 

  8. Swearingen B. et al. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J. Clin. Endocrinol. Metab. 83, 3419–3426 (1998).

    CAS  PubMed  Google Scholar 

  9. Sherlock, M. et al. A paradigm shift in the monitoring of patients with acromegaly: last available growth hormone may overestimate risk. J. Clin. Endocrinol. Metab. 99, 478–485 (2014).

    Article  CAS  Google Scholar 

  10. Burgers, A. M. et al. Meta-analysis and dose-response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality. J. Clin. Endocrinol. Metab. 96, 2912–2920 (2011).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology (Center of Endocrine Tumors), Leiden University Medical Center, Box 9600, Leiden, 2300, RC, Netherlands

    Nienke R. Biermasz

Authors
  1. Nienke R. Biermasz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nienke R. Biermasz.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Biermasz, N. Mortality in acromegaly reduced with multimodal therapy. Nat Rev Endocrinol 10, 708–710 (2014). https://doi.org/10.1038/nrendo.2014.193

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2014.193

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing